Valuation: 4DMedical Limited

Market Cap 2.34B 1.66B 1.43B 1.35B 1.23B 2.31B 158B 15.84B 6.18B 79.08B 6.21B 6.08B 264B P/E 2026 *
-12.3x
P/E 2027 * -62.3x
Enterprise Value 2.08B 1.47B 1.27B 1.19B 1.09B 2.05B 140B 14.05B 5.49B 70.16B 5.51B 5.39B 234B EV / Sales 2026 *
249x
EV / Sales 2027 * 95.1x
Free-Float
93.57%
Yield 2026 *
-
Yield 2027 * -
1 day-6.91%
1 week-13.74%
Current month+0.28%
1 month-6.91%
3 months-4.96%
6 months-4.21%
Current year-7.38%
1 week 3.64
Extreme 3.64
4.47
1 month 3.06
Extreme 3.06
4.99
Current year 2.95
Extreme 2.95
7.55
1 year 0.47
Extreme 0.472
7.55
3 years 0.22
Extreme 0.225
7.55
5 years 0.22
Extreme 0.225
7.55
10 years 0.22
Extreme 0.225
7.55
Manager TitleAgeSince
Chief Executive Officer - 01/12/2012
Director of Finance/CFO - 02/01/2026
Chief Tech/Sci/R&D Officer - 01/04/2023
Director TitleAgeSince
Director/Board Member - 01/12/2012
Chairman - 02/11/2023
Director/Board Member - 01/10/2017
Date Insider Type Main position Quantity % Market Cap.
18/06/26 Buy

Chief Financial Officer

13,054 0.0022%
22/01/26 Sell

Chief Financial Officer

2,666,666 0.5078%
22/01/26 Sell

Founder

263,157 0.0501%
Change 5-day change 1-year change 3-year change Capi.($)
-6.91%-13.74%+586.79%+402.07% 1.66B
-1.18%+2.74%+22.92%+9.58% 220B
-0.92%+1.96%-2.51%-20.17% 143B
0.00%+7.37%-16.81%+31.78% 142B
+0.53%+4.85%-49.57%+1.29% 74.91B
-0.53%+3.63%+19.16%+16.56% 53.35B
+0.87%-0.33%-15.82%-16.41% 50.13B
+0.71%+5.62%+24.11%+17.68% 42.16B
-0.63%+3.46%+39.31%+41.78% 40.63B
+2.09%+4.95%-2.04%+3.07% 33.33B
Average -0.39%+1.97%+60.55%+48.72% 80.16B
Weighted average by Cap. -0.15%+3.80%+2.92%+8.85%

Financials

2026 *2027 *
Net sales 8.34M 5.89M 5.1M 4.78M 4.36M 8.21M 562M 56.34M 21.99M 281M 22.11M 21.63M 938M 22.25M 15.71M 13.62M 12.77M 11.64M 21.9M 1.5B 150M 58.68M 751M 58.98M 57.71M 2.5B
Net income -177M -125M -108M -102M -92.61M -174M -11.93B -1.2B -467M -5.97B -469M -459M -19.92B -37.1M -26.19M -22.7M -21.28M -19.4M -36.51M -2.5B -251M -97.83M -1.25B -98.33M -96.2M -4.17B
Net Debt -264M -187M -162M -152M -138M -260M -17.82B -1.79B -697M -8.92B -701M -686M -29.76B -228M -161M -140M -131M -119M -225M -15.39B -1.54B -602M -7.7B -605M -592M -25.69B
Logo 4DMedical Limited
4DMedical Limited is a medical technology company that creates and deploys software-based cardiothoracic imaging technology integrating both algorithms and artificial intelligence. The Company's software platform delivers quantitative insights from routine clinical imaging to help clinicians assess lung function and cardiopulmonary disease. It provides thoracic imaging that enhances physician diagnoses and management of respiratory conditions. Its products include CT:VQ-Non-Contrast Ventilation-Perfusion, CAC-Coronary Artery Calcification, CT LVAS-Lung Ventilation Analysis, IQ-UIP-Early IPF Detection, LDAf-Functional Lung Density Analysis, LDAi-Lung Density Analysis – Inspiration, LTA-Lung Texture Analysis, PHA-Pulmonary Hypertension Assessment, XV LVAS-Lung Ventilation Analysis, and Companion Imaging. The CT:VQ is a non-contrast post-processing technology that transforms routine, chest computed tomographies (CTs) into quantitative, lobar ventilation (V) and perfusion (Q) maps.
Employees
-
Date Price Change Volume
14/08/26 A$3.640 -6.91% 6,340,289
13/08/26 A$3.910 -5.10% 4,334,860
12/08/26 A$4.120 +0.98% 4,483,853
11/08/26 A$4.080 -7.27% 6,000,072
10/08/26 A$4.400 +4.27% 5,857,006
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3.910AUD
Average target price
4.967AUD
Spread / Average Target
+27.02%

Quarterly revenue - Rate of surprise